EP1051169A4 - Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases - Google Patents
Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesInfo
- Publication number
- EP1051169A4 EP1051169A4 EP99905546A EP99905546A EP1051169A4 EP 1051169 A4 EP1051169 A4 EP 1051169A4 EP 99905546 A EP99905546 A EP 99905546A EP 99905546 A EP99905546 A EP 99905546A EP 1051169 A4 EP1051169 A4 EP 1051169A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- treating
- compounds
- methods
- associated diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7303898P | 1998-01-29 | 1998-01-29 | |
US73038P | 1998-01-29 | ||
US7307898P | 1998-01-30 | 1998-01-30 | |
US73078P | 1998-01-30 | ||
PCT/US1999/001985 WO1999038508A1 (en) | 1998-01-29 | 1999-01-29 | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1051169A1 EP1051169A1 (en) | 2000-11-15 |
EP1051169A4 true EP1051169A4 (en) | 2002-05-29 |
Family
ID=26754055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99905546A Withdrawn EP1051169A4 (en) | 1998-01-29 | 1999-01-29 | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1051169A4 (en) |
JP (1) | JP2002501894A (en) |
CN (1) | CN1289248A (en) |
AU (1) | AU759772B2 (en) |
BR (1) | BR9908522A (en) |
CA (1) | CA2319465C (en) |
MX (1) | MXPA00007394A (en) |
NZ (1) | NZ505894A (en) |
WO (1) | WO1999038508A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489338B2 (en) | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
KR20040058229A (en) | 2001-10-22 | 2004-07-03 | 더 스크립스 리서치 인스티튜트 | Antibody targeting compounds |
CA2495266A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
US8119672B2 (en) * | 2002-08-09 | 2012-02-21 | Microdose Therapeutx, Inc. | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
WO2005042530A1 (en) | 2003-10-30 | 2005-05-12 | Boehringer Ingelheim (Canada) Ltd. | Rsv polymerase inhibitors |
PL1706385T3 (en) | 2003-12-23 | 2011-03-31 | Astex Therapeutics Ltd | Pyrazole derivatives as protein kinase modulators |
JP2008546751A (en) | 2005-06-22 | 2008-12-25 | アステックス・セラピューティクス・リミテッド | Pharmaceutical composition |
JP5345842B2 (en) | 2005-06-23 | 2013-11-20 | アステックス・セラピューティクス・リミテッド | Pharmaceutical combinations containing pyrazole derivatives as protein kinase modulators |
GB0704932D0 (en) | 2007-03-14 | 2007-04-25 | Astex Therapeutics Ltd | Pharmaceutical compounds |
JP2012517447A (en) | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | Chemically programmed vaccination methods |
NZ628880A (en) | 2012-06-29 | 2016-08-26 | Microdose Therapeutx Inc | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
WO2015085844A1 (en) | 2013-12-10 | 2015-06-18 | 南京明德新药研发股份有限公司 | Imidazole derivative used as antiviral agent and use thereof in preparation of medicament |
PT3305790T (en) | 2015-06-08 | 2020-10-19 | Shangdong Danhong Pharmaceutical Co Ltd | Method for preparing imidazole derivative and intermediate thereof and crystal form |
EP3982994A4 (en) * | 2019-06-13 | 2023-10-04 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of respiratory syncytial virus |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1508391A (en) * | 1975-01-20 | 1978-04-26 | Sterling Drug Inc | Phenylalkylamines |
US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
US5098920A (en) * | 1990-05-04 | 1992-03-24 | G. D. Searle & Co. | 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders |
WO1995000131A1 (en) * | 1993-06-23 | 1995-01-05 | Cambridge Neuroscience, Incorporated | Sigma receptor ligands and the use thereof |
EP0795549A1 (en) * | 1996-02-13 | 1997-09-17 | American Cyanamid Company | Bis-aryloxy(amino)-triazinyl-oxy(amino)aryl derivatives, their preparation and their use as antiviral agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124280A (en) * | 1995-07-27 | 2000-09-26 | Warner-Lambert Company | Substituted phenols as novel calcium channel blockers |
DE69706407T2 (en) * | 1996-03-29 | 2002-05-29 | G.D. Searle & Co., Chicago | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTERGRIN ANTAGONISTS OR INHIBITORS |
-
1999
- 1999-01-29 WO PCT/US1999/001985 patent/WO1999038508A1/en not_active Application Discontinuation
- 1999-01-29 BR BR9908522-4A patent/BR9908522A/en not_active Application Discontinuation
- 1999-01-29 AU AU25685/99A patent/AU759772B2/en not_active Ceased
- 1999-01-29 CN CN99802500A patent/CN1289248A/en active Pending
- 1999-01-29 MX MXPA00007394A patent/MXPA00007394A/en unknown
- 1999-01-29 NZ NZ505894A patent/NZ505894A/en unknown
- 1999-01-29 CA CA2319465A patent/CA2319465C/en not_active Expired - Lifetime
- 1999-01-29 EP EP99905546A patent/EP1051169A4/en not_active Withdrawn
- 1999-01-29 JP JP2000529241A patent/JP2002501894A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1508391A (en) * | 1975-01-20 | 1978-04-26 | Sterling Drug Inc | Phenylalkylamines |
US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
US5098920A (en) * | 1990-05-04 | 1992-03-24 | G. D. Searle & Co. | 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders |
WO1995000131A1 (en) * | 1993-06-23 | 1995-01-05 | Cambridge Neuroscience, Incorporated | Sigma receptor ligands and the use thereof |
EP0795549A1 (en) * | 1996-02-13 | 1997-09-17 | American Cyanamid Company | Bis-aryloxy(amino)-triazinyl-oxy(amino)aryl derivatives, their preparation and their use as antiviral agents |
Non-Patent Citations (4)
Title |
---|
BAKER, B.R. ET AL: "Irreversible Enzyme Inhibitors. 181. Inhibition of Brain Choline Acetyltransferase by Derivatives of 4-Stilbazole", J. MED. CHEM., 1984, pages 315 - 322, XP000938518 * |
DE CLERCQ, ERIK: "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 7, 1996, pages 193 - 202, XP002193685 * |
SCHLEGEL, DONALD C. ET AL: "Bulky amine analogs of ketoprofen: potent antiinflammatory agents", J. MED. CHEM. (1984), 27(12), 1682-90, XP000973055 * |
See also references of WO9938508A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999038508A1 (en) | 1999-08-05 |
AU759772B2 (en) | 2003-05-01 |
CA2319465C (en) | 2013-03-19 |
CN1289248A (en) | 2001-03-28 |
MXPA00007394A (en) | 2003-08-01 |
BR9908522A (en) | 2001-10-02 |
CA2319465A1 (en) | 1999-08-05 |
JP2002501894A (en) | 2002-01-22 |
NZ505894A (en) | 2002-12-20 |
EP1051169A1 (en) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1128832A4 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
EP1109580A4 (en) | Methods for treating or preventing viral infections and associated diseases | |
EP1115286A4 (en) | Methods for treating or preventing viral infections and associated diseases | |
HUP0100765A3 (en) | Composition for the treatment of halitosis | |
IL142906A0 (en) | Methods and compositions for treating or preventing peripheral neuropathies | |
AUPQ127399A0 (en) | Compositions and methods for treating or preventing osteoporosis | |
HK1048987A1 (en) | Compounds, compositions, and methods for stimulating neuronal growth and elongation | |
ZA200007642B (en) | Treatment of airborne microorganisms. | |
ZA200108215B (en) | Compositions and methods for treatment of staphylococcal infection. | |
EP1109548A4 (en) | Compositions and methods for treating and preventing bone diseases using tocotrienols | |
EP1051169A4 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
AU4314199A (en) | Compounds, compositions and methods for treating erectile dysfunction | |
HK1041827A1 (en) | Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame. | |
EP0920419A4 (en) | Compounds, compositions and methods for treating influenza | |
ZA200203435B (en) | Method and compositions for treating pulmonary diseases. | |
IL133760A0 (en) | Composition for the treatment of dandruff | |
AU2003258176A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
GB9917593D0 (en) | Compound, composition, process and use | |
PL345068A1 (en) | Novel compounds derived from α-d-xylose, preparation method and therapeutic use | |
AU6798000A (en) | Compounds, compositions and methods for treating influenza | |
AU2003258177A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
PL345598A1 (en) | Compounds, compositions, and methods for stimulating neuronal growth and elongation | |
ZA200007396B (en) | Method of treatment. | |
HU9900123D0 (en) | 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof | |
AU3698199A (en) | Radioimmuno-pharmacon for treating the hiv-1 infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000807 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07D 257/06 A, 7A 61K 31/41 B, 7C 07D 249/14 B, 7C 07D 257/04 B, 7C 07D 277/24 B, 7C 07D 261/08 B, 7C 07D 401/10 B, 7C 07D 233/54 B, 7A 61K 31/415 B, 7A 61K 31/42 B, 7A 61K 31/425 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020412 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20021008 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040817 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1029938 Country of ref document: HK |